Podcast

Epocrates: A Decade on Top

We spoke with Dr. Kent Willyard about his experience using Epocrates since it was introduced to healthcare professionals.

We spoke with Dr. Kent Willyard about his experience using Epocrates since it was introduced to healthcare professionals.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Related Content
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision | HCPLive.com
December 21st 2024

Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision

Isabella Ciccone, MPH
Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management
December 17th 2024

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH
FDA black and white logo | Credit: US Food and Drug Administration
December 19th 2024

FDA Issues CRL to Glepaglutide for Short Bowel Syndrome, Cites Insufficient Evidence

Abigail Brooks, MA
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
December 16th 2024

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Edoardo Cipolletta, MD, Academic Rheumatology, School of Medicine, Nottingham City Hospital, University of Nottingham, United Kingdom,
December 19th 2024

Colchicine Prophylaxis for Gout Flares Linked to Lower Cardiovascular Events

Victoria Johnson
Esi Lamousé-Smith, MD, PhD | Credit: Johnson & Johnson
December 18th 2024

J&J Submits sBLA for Golimumab (Simponi) for Pediatric Ulcerative Colitis

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.